Rostock, Germany

Marian Loebler

This inventor holds 1 USPTO granted patent. Top assignee: Universitaet Rostock. Active years: 2019.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Glaucoma Treatment by Marian Loebler

Introduction

Marian Loebler is an accomplished inventor based in Rostock, Germany. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach aims to improve the quality of life for patients suffering from this condition.

Latest Patents

Marian Loebler holds a patent for a glaucoma drainage implant. This ocular implant is designed to treat glaucoma by facilitating the drainage of aqueous humor from the anterior chamber of the eye into the subconjunctival or suprachoroidal space. The invention addresses the critical issue of lowering intraocular pressure in glaucoma cases. It aims to eliminate the drawbacks associated with existing valve mechanisms while being economical to produce. The glaucoma drainage implant consists of an elongate, hollow main member that incorporates a flow-limiting membrane in the inflow region.

Career Highlights

Marian Loebler is affiliated with the University of Rostock, where he continues to engage in research and development in the field of ophthalmology. His work has garnered attention for its potential to revolutionize glaucoma treatment.

Collaborations

Marian has collaborated with notable colleagues, including Stefan Siewert and Frank Luderer, to advance his research and innovations in the field.

Conclusion

Marian Loebler's contributions to glaucoma treatment through his innovative drainage implant highlight the importance of research and development in improving patient outcomes. His work exemplifies the potential of inventions to address critical medical challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…